These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Legionnaires' disease in a patient with polymyositis. McDonald KS; Faoagali JL; Tait GB; Moller PW N Z Med J; 1980 Jun; 91(662):451-2. PubMed ID: 6967573 [TBL] [Abstract][Full Text] [Related]
5. Legionella pneumophila pneumonia in a renal transplant patient. Gafter U; Shapira Z; Boner G; Zevin D; Levi J Isr J Med Sci; 1983 Mar; 19(3):274-6. PubMed ID: 6343293 [No Abstract] [Full Text] [Related]
6. Antimicrobial therapy of experimental Legionella micdadei pneumonia in guinea pigs. Pasculle AW; Dowling JN; Frola FN; McDevitt DA; Levi MA Antimicrob Agents Chemother; 1985 Dec; 28(6):730-4. PubMed ID: 3878688 [TBL] [Abstract][Full Text] [Related]
8. In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia. Edelstein PH; Edelstein MA Antimicrob Agents Chemother; 1999 Jan; 43(1):90-5. PubMed ID: 9869571 [TBL] [Abstract][Full Text] [Related]
9. In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia. Edelstein PH; Edelstein MA; Weidenfeld J; Dorr MB Antimicrob Agents Chemother; 1990 Nov; 34(11):2122-7. PubMed ID: 2073101 [TBL] [Abstract][Full Text] [Related]
10. Treatment of legionnaires' disease. Klein NC; Cunha BA Semin Respir Infect; 1998 Jun; 13(2):140-6. PubMed ID: 9643392 [TBL] [Abstract][Full Text] [Related]
11. A new macrolide, TE-031 (A-56268), in treatment of experimental Legionnaires' disease. Kohno S; Koga H; Yamaguchi K; Masaki M; Inoue Y; Dotsu Y; Masuyama Y; Hayashi T; Hirota M; Saito A J Antimicrob Chemother; 1989 Sep; 24(3):397-405. PubMed ID: 2530201 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of azithromycin in the treatment of guinea pigs infected with Legionella pneumophila by aerosol. Fitzgeorge RB; Featherstone AS; Baskerville A J Antimicrob Chemother; 1990 Jan; 25 Suppl A():101-8. PubMed ID: 2154427 [TBL] [Abstract][Full Text] [Related]
14. Atypical pneumonia caused by dual infection with Legionella pneumophila and Mycoplasma pneumoniae. Nunn C; Chereshsky A; Pearce JL N Z Med J; 1990 Oct; 103(900):512-3. PubMed ID: 2122336 [No Abstract] [Full Text] [Related]
15. Legionnaires' disease: a rare entity in Puerto Rico? Príncipe Rodríguez K; Rodríguez Cintrón W P R Health Sci J; 2001 Sep; 20(3):251-3. PubMed ID: 11776727 [TBL] [Abstract][Full Text] [Related]
16. Another look at trimethoprim-sulfamethoxazole: its role in parenteral therapy. Sattler FR; Remington JS Eur J Clin Microbiol; 1984 Jun; 3(3):174-6. PubMed ID: 6332015 [No Abstract] [Full Text] [Related]
17. Comparison of spiramycin and erythromycin in the treatment of experimental guinea pig legionellosis. Dournon E; Rajagopalan P J Antimicrob Chemother; 1988 Jul; 22 Suppl B():69-72. PubMed ID: 3182448 [TBL] [Abstract][Full Text] [Related]